NVP

11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE

NVP is found in 22 entries

NVP as free ligands, exist in 22 entries. Examples include 1FKP, 1JLB, 1JLF

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
Identifiers 11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
Synonyms NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
Formula C15 H14 N4 O
Molecular Weight 266.30 g/mol
Type non-polymer
Isomeric SMILES Cc1ccnc2N(C3CC3)c3ncccc3C(=O)Nc12
InChI InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
InChI Key NQDJXKOVJZTUJA-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 34
Chiral Atom Count 0
Chiral Atoms
Bond Count 37
Aromatic Bond Count 12

Drug Info: DrugBank

DrugBank ID DB00238   (Stereoisomeric match)
Name Nevirapine
Groups approved
Description A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. [PubChem] Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
Synonyms
  • 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
  • NEV
  • Nevirapine
  • NVP
  • Viramune
Brand Names
  • Apo-nevirapine
  • Apo-nevirapine XR
  • Auro-nevirapine
  • Mylan-nevirapine
  • Nevirapine
  • Nevirapine Extended Release
  • PMS-nevirapine
  • Teva-nevirapine
  • Viramune
  • Viramune XR
[more]
Affected Organism Human Immunodeficiency Virus
Indication For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
Pharmacology Nevirapine is a non-nucleoside reverse transcriptase inhibitor (nNRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). HIV-2 RT and eukaryotic DNA polymerases (such as human DNA polymerases alpha, beta, or sigma) are not inhibited by nevirapine. Nevirapine is, in general, only prescribed after the immune system has declined and infections have become evident. It is always taken with at least one other HIV medication such as Retrovir or Videx. The virus can develop resistance to nevirapine if the drug is taken alone, although even if used properly, nevirapine is effective for only a limited time.
Mechanism of action Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates.
Route of administration oral
Categories
  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Inducers of Drug Clearance
  • CYP2B6 Inducers (Strong)
ATC-Code J05AG01
AHFS-Code 08:18.08.16
CAS number 129618-40-2
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682